Taiwan FDA registration ecf9c98e131dfb463bd1e54555be892f
Glycated hemoglobin detection panel
TW: 糖化血色素檢測試劑組
Taiwan·Risk Class 2·Trinity Biotech (Primus Corporation dba Trinity Biotech)·Registered Nov 28, 2013 – Nov 28, 2023ExpiredRegistration details
- Analysis ID
- ecf9c98e131dfb463bd1e54555be892f
- Customs Code
- DHA05602555904
Company information
- Manufacturer Country
- United States
- Authorized Representative
- PROGRESSIVE GROUP INC.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical); B.7470 Analysis of glycosylated hemoglobin
- Import Information
- import
Dates and status
- Registration Date
- Nov 28, 2013
- Expiry Date
- Nov 28, 2023
About this record
Access comprehensive regulatory information for Glycated hemoglobin detection panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ecf9c98e131dfb463bd1e54555be892f and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices